Latest Breaking News On - Mary ann ondish - Page 8 : comparemela.com

ADC Therapeutics and Sobi Announce ZYNLONTA® (loncastuximab tesirine) Receives Positive CHMP Opinion in Europe for the Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma

ADC Therapeutics and Sobi Announce ZYNLONTA® (loncastuximab tesirine) Receives Positive CHMP Opinion in Europe for the Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesNew jerseyCity ofAmanda loshbaughLausanne biopMary ann ondishAnders ullmanJohn radfordEugenia litzCompany on twitterMitsubishi tanabe pharma corporationEuropean commissionUniversity of manchesterDrug administrationFoundation trust in manchester

ADC Therapeutics to Participate in Morgan Stanley s 20th Annual Global Healthcare Conference

ADC Therapeutics SA (NYSE: ADCT) announced today that Ameet Mallik, Chief Executive Officer, will participate in a fireside chat at Morgan Stanley's 20th Annual Global Healthcare Conference on Tuesday

New jerseyUnited statesCity ofUnited kingdomLausanne biopMary ann ondishEugenia litzAmanda hamiltonMorgan stanleyCompany on twitterAmeet mallikChief executive officerAnnual global healthcare conferenceEvents presentationsSan francisco bay areaAnn ondish

ADC Therapeutics to Host Second Quarter 2022 Financial Results Conference Call on August 9, 2022

LAUSANNE, Switzerland (BUSINESS WIRE) ADC Therapeutics SA (NYSE: ADCT) today announced that it will host a conference call and live webcast on Tuesday, August 9, 2022 at 8:30 a.m. ET to report financial results for the second quarter 2022 and provide business updates.To access the conference call, please register.

New jerseyUnited statesCity ofUnited kingdomLausanne biopMary ann ondishEugenia litzAmanda hamiltonCompany on twitterSan francisco bay area

ADC Therapeutics SA: ADC Therapeutics Announces First Patient Dosed in Phase 2 Clinical Trial of ZYNLONTA (loncastuximab tesirine-lpyl) in Combination with Rituximab in First-Line Diffuse Large B-Cell Lymphoma

ADC Therapeutics SA: ADC Therapeutics Announces First Patient Dosed in Phase 2 Clinical Trial of ZYNLONTA (loncastuximab tesirine-lpyl) in Combination with Rituximab in First-Line Diffuse Large B-Cell Lymphoma
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

New jerseyUnited statesCity ofUnited kingdomLausanne biopMary ann ondishFondazione italiana linfomiEugenia litzJoseph camardoAmanda hamiltonExchange commissionCompany on twitterDrug administrationChief medical officerCumulative illness rating scaleSan francisco bay area

ADC Therapeutics Appoints Jean-Pierre Bizzari, MD, to Board of Directors

ADC Therapeutics Appoints Jean-Pierre Bizzari, MD, to Board of Directors
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesFrance generalNew jerseyCity ofUnited kingdomLausanne biopMary ann ondishPoulenc rorerJean pierre bizzariEugenia litzAmanda hamiltonMcgill rosalindMorris goodman cancer research centreCompany on twitterFrance national cancer instituteEuropean organisation for research